Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48,688 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical Study.
Wynne CJ, Cole A, Lemech C, Wang G, Zhang Y, Chen B, Wang M, Li B, Xia M, Sinclair R. Wynne CJ, et al. Among authors: wang g, wang m. Dermatol Ther (Heidelb). 2023 Oct;13(10):2357-2373. doi: 10.1007/s13555-023-01010-1. Epub 2023 Sep 5. Dermatol Ther (Heidelb). 2023. PMID: 37668898 Free PMC article.
Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study.
Jiang C, Zhou H, Zhang W, Xia Y, Li B, Ni X, Wang G, Zhang W, Chen B, He Z, Zhang M, Chen R, Jin H, Deng L. Jiang C, et al. Among authors: wang g. Dermatol Ther (Heidelb). 2023 Feb;13(2):555-567. doi: 10.1007/s13555-022-00880-1. Epub 2022 Dec 24. Dermatol Ther (Heidelb). 2023. PMID: 36566344 Free PMC article.
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab.
Zhang Y, Pei Z, Chen B, Qu Y, Dong X, Yu B, Wang G, Xu F, Lu D, He Z, Chen B, Ma L, Wang M, Li B, Xia M, Zheng B, Huo Y. Zhang Y, et al. Among authors: wang g, wang m. Pharmacol Res. 2024 Sep;207:107340. doi: 10.1016/j.phrs.2024.107340. Epub 2024 Aug 5. Pharmacol Res. 2024. PMID: 39111557 Free article. Clinical Trial.
Photoluminescence Switching in Quantum Dots Connected with Carboxylic Acid and Thiocarboxylic Acid End-Group Diarylethene Molecules.
Sarabamoun ES, Aryal P, Bietsch JM, Curran M, Verma S, Johnson G, Yoon LU, Reid AG, Tsai EHR, Machan CW, Paolucci C, Wang G, Choi JJ. Sarabamoun ES, et al. Among authors: wang g. J Phys Chem C Nanomater Interfaces. 2024 Nov 21;128(48):20599-20608. doi: 10.1021/acs.jpcc.4c04978. eCollection 2024 Dec 5. J Phys Chem C Nanomater Interfaces. 2024. PMID: 39660081 Free PMC article.
On networks of space-based gravitational-wave detectors.
Cai RG, Guo ZK, Hu B, Liu C, Lu Y, Ni WT, Ruan WH, Seto N, Wang G, Wu YL. Cai RG, et al. Among authors: wang g. Fundam Res. 2023 Nov 8;4(5):1072-1085. doi: 10.1016/j.fmre.2023.10.007. eCollection 2024 Sep. Fundam Res. 2023. PMID: 39659501 Free PMC article. Review.
48,688 results
You have reached the last available page of results. Please see the User Guide for more information.